Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Screen Shot 2015-07-29 at 11.09.41

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


greg-grindley-lead

Interviews

Dancing with my wife again: Greg Grindley on life one year after Brain Surgery Live

Find out how the man who had DBS live on TV is doing one year on

READ MORE
Google-contact-lens

Advances

Google reveals huge plans to fight Parkinson’s

The tech giant is pumping funds into new life sciences team

READ MORE
Pearl barley risotto lead

Recipes & Nutrition

Pearl barley risotto with southern vegetables

Rice is swapped for pearl barley in this risotto with a twist

READ MORE